1. Home
  2. AFYA vs PGEN Comparison

AFYA vs PGEN Comparison

Compare AFYA & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Afya Limited

AFYA

Afya Limited

HOLD

Current Price

$13.42

Market Cap

1.4B

Sector

Real Estate

ML Signal

HOLD

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$3.66

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AFYA
PGEN
Founded
1999
1998
Country
Brazil
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.6B
IPO Year
2019
2013

Fundamental Metrics

Financial Performance
Metric
AFYA
PGEN
Price
$13.42
$3.66
Analyst Decision
Hold
Buy
Analyst Count
5
5
Target Price
$17.00
$7.67
AVG Volume (30 Days)
90.3K
4.2M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
1.71%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$230,981,000.00
Revenue This Year
$14.67
$342.78
Revenue Next Year
$7.84
$478.46
P/E Ratio
$9.30
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.12
$1.11
52 Week High
$19.76
$5.47

Technical Indicators

Market Signals
Indicator
AFYA
PGEN
Relative Strength Index (RSI) 31.69 33.80
Support Level N/A $3.49
Resistance Level $15.35 $5.10
Average True Range (ATR) 0.40 0.36
MACD -0.12 -0.13
Stochastic Oscillator 10.95 1.57

Price Performance

Historical Comparison
AFYA
PGEN

About AFYA Afya Limited

Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergrad provides educational services through undergraduate courses related to medical school, undergraduate health science and other ex-health undergraduate programs, Continuing Education provides medical education, specialization and graduate courses in medicine, delivered through digital and in-person content; and Medical practice solution provides clinical decision, clinical management and doctor-patient relationships for physicians and provide access, demand and efficiency for the healthcare players.

About PGEN Precigen Inc.

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

Share on Social Networks: